Sign-up for a FREE trial here. ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD announced the pricing of an underwritten public offering of 6,060,606 shares of its common stock, offered at a price to the public of $33.00 per share. The gross …
Regenerative medicine-focused biotech Athersys, Inc (NASDAQ:ATHX) put some vim into its share price with ... which was way ahead of the $3.72mln tipped by analysts that follow the stock. Shares rose 17% to $2.14 on the results. The …
Athersys, Inc. (ATHX) said Friday that it has agreed to sell about 19.8 million shares of common stock through an underwritten public offering at $1.01 per share, which was the closing price of its common stock on October 25. In …
In such a scenario, we advise investors to forget Gilead, a Zacks Rank #4 (Sell) stock, and invest in some other small cap biotech stocks (market capitalization ... Headquartered in Cleveland, Ohio, Athersys, Inc. ATHX is developing its …
The company has shown significant progress with its pipeline - Tecfidera's approval is a major boost for the stock. We are also positive on Biogen's gaining full control over Tysabri. Key products, Avonex and Tysabri, should continue …
Ladder Capital Corp (NYSE: LADR) (“Ladder” or the “Company”) announced today that the previously announced underwritten secondary public offering of 10,000,000 shares of the Company’s Class A common stock priced at a price …
Here are today’s five biggest gaining stocks at closing: Comstock Holding Companies Inc. (NASDAQ: CHCI) is up 59.8% at $1.87. Redhill Biopharma Ltd. (NASDAQ: RDHL) is up 41.3% at $11.95. ... Read Full Story »
Nasdaq climbed 15 points to finish the session at 2252. On the upside Shares of Athersys (Nasdaq: ATHX) more than doubled following an analyst upgrade with a price target of $8 a share. American International Group (NYSE: AIG) …
Starbucks Corporation (NASDAQ: SBUX) stock have continued to struggle ever since the coffeemaker's shares topped out last October. And as unpleasant as it might be to hear, the path of least resistance - given the broader economic …